Integrated Diagnostics (LON:IDHC) Hits New 52-Week Low – Should You Sell?

Integrated Diagnostics Holdings plc (LON:IDHC) shares reached a new 52-week low during mid-day trading on Friday. The stock traded as low as GBX 0.48 and last traded at GBX 0.50, with a volume of 6,968 shares trading hands. The stock had previously closed at GBX 0.49.

Integrated Diagnostics Stock Performance

The company has a quick ratio of 0.75, a current ratio of 1.67 and a debt-to-equity ratio of 42.91. The company has a market cap of £2.91 million, a P/E ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.44. The business has a fifty day moving average of GBX 0.53 and a 200 day moving average of GBX 0.55.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.